Trade Summary

2 days ago, Kumar Rashmi, serving as Dir at MYRIAD GENETICS INC (MYGN), sold 15,000 shares at $4.46 per share, for a total transaction value of $66,843.00. Following this transaction, Kumar Rashmi now holds 171,889 shares of MYGN.

This sale represents a 8.03% decrease in Kumar Rashmi's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 8, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 9, 2026 at 4:20 PM ET, 1 day after the trade was made.

MYRIAD GENETICS INC operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.